|
Appeals Court Upholds Exclusion of Purdue Execs; Rejects ‘Arbitrary’ Penalty Period
A U.S. appeals court has ruled HHS was “unambiguously” justified in excluding three former Purdue Pharma executives from federal healthcare programs after they pleaded guilty to charges the company illegally marketed and promoted its painkiller Oxycontin.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives